Peel Hunt Reaffirms Buy Rating for Diploma (LON:DPLM)

Diploma (LON:DPLM)‘s stock had its “buy” rating reiterated by analysts at Peel Hunt in a report issued on Tuesday,London Stock Exchange reports. They presently have a GBX 6,150 price objective on the stock. Peel Hunt’s target price indicates a potential upside of 16.26% from the stock’s previous close.

A number of other equities research analysts also recently weighed in on DPLM. Jefferies Financial Group raised their target price on shares of Diploma from GBX 4,500 to GBX 5,200 and gave the company a “hold” rating in a research note on Thursday, September 11th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a GBX 4,440 price objective on shares of Diploma in a report on Wednesday, August 6th. Royal Bank Of Canada raised Diploma to an “outperform” rating and increased their target price for the company from GBX 4,500 to GBX 6,000 in a research note on Friday, October 3rd. Finally, Berenberg Bank raised their price target on Diploma from GBX 5,750 to GBX 6,350 and gave the company a “buy” rating in a research report on Wednesday, September 10th. Four research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of GBX 5,477.14.

Diploma Price Performance

Diploma stock traded up GBX 30 during midday trading on Tuesday, hitting GBX 5,290. 1,069,203 shares of the company’s stock were exchanged, compared to its average volume of 545,996. The company has a market cap of £7.09 billion, a P/E ratio of 42.56, a PEG ratio of 2.82 and a beta of 0.75. The company has a debt-to-equity ratio of 62.17, a quick ratio of 0.80 and a current ratio of 2.17. The stock has a 50-day moving average price of GBX 5,416.45 and a two-hundred day moving average price of GBX 5,103.65. Diploma has a 52-week low of GBX 3,532 and a 52-week high of GBX 5,700.

About Diploma

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.